(Q64606739)

English

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS (English)

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

United States of America

0 references

start time

7 November 2014

0 references

end time

18 September 2021

0 references

number of participants

163

0 references

clinical trial phase

phase IV clinical trial

0 references

research site

University of Southern California

0 references

Washington University in St. Louis

0 references

Washington University School of Medicine

0 references

University of Washington

0 references

Medical University of Innsbruck

0 references

Hospital Clinic of Barcelona

0 references

Hospital Universitario de La Princesa

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02228382

0 references

(Q64606739)

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)